1. 13th Annual Meeting of the Safety Pharmacology Society: focus on novel technologies and safety pharmacology frontiers. (September 2014) Authors: Cavero, Icilio Journal: Expert opinion on drug safety Issue: Volume 13:Number 9(2014) Page Start: 1271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 14th Annual Meeting of the Safety Pharmacology Society: threading through scientific sessions for originality and novelty. (June 2015) Authors: Cavero, Icilio Journal: Expert opinion on drug safety Issue: Volume 14:Number 6(2015:Nov.) Page Start: 999 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 18th Annual Meeting of the Safety Pharmacology Society: drug safety assessment on gastrointestinal system functions. Issue 1 (2nd January 2020) Authors: Cavero, Icilio; Holzgrefe, Henry H. Journal: Expert opinion on drug safety Issue: Volume 19:Issue 1(2020) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 18th world congress of basic and clinical pharmacology: thought-provoking lectures on drug safety issues. Issue 12 (2nd December 2019) Authors: Cavero, Icilio; Holzgrefe, Henry H Journal: Expert opinion on drug safety Issue: Volume 18:Issue 12(2019) Page Start: 1145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 19th Annual Meeting of the Safety Pharmacology Society: regulatory and safety perspectives for advanced therapy medicinal products (cellular and gene therapy products). Issue 5 (3rd May 2020) Authors: Cavero, Icilio; Seimetz, Diane; Koziel, David; Zimmermann, Wolfram-Hubertus; Holzgrefe, Henry H Journal: Expert opinion on drug safety Issue: Volume 19:Issue 5(2020) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2012 Annual Meeting of the Safety Pharmacology Society: spotlight on targeted oncology medicines. (July 2013) Authors: Cavero, Icilio Journal: Expert opinion on drug safety Issue: Volume 12:Number 4(2013:Jul.) Page Start: 589 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 5-Hydroxytryptamine3 receptor antagonists and cardiac side effects. (October 2014) Authors: Brygger, Louise; Herrstedt, Jørn Journal: Expert opinion on drug safety Issue: Volume 13:Number 10(2014) Page Start: 1407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A characterization and disproportionality analysis of medication error related adverse events reported to the FAERS database. Issue 12 (2nd December 2018) Authors: Carnovale, Carla; Mazhar, Faizan; Pozzi, Marco; Gentili, Marta; Clementi, Emilio; Radice, Sonia Journal: Expert opinion on drug safety Issue: Volume 17:Issue 12(2018) Page Start: 1161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A comparative review of current topical antibiotics for impetigo. Issue 6 (3rd June 2021) Authors: Galindo, Eugenio; Hebert, Adelaide A Journal: Expert opinion on drug safety Issue: Volume 20:Issue 6(2021) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment. Issue 3 (4th March 2018) Authors: Consoli, Agostino; Formoso, Gloria; Baldassarre, Maria Pompea Antonia; Febo, Fabrizio Journal: Expert opinion on drug safety Issue: Volume 17:Issue 3(2018) Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗